Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
REVITALIZE study to evaluate laser therapy for vaginal dryness after breast cancer treatment
The Alliance for Clinical Trials in Oncology is now enrolling patients into a clinical trial…
AACR 2026: Exposure to wildfire smoke may be linked to increased risk of developing several cancers
Exposure to wildfire smoke was associated with a significantly increased risk of lung, colorectal, breast,…
Genetic discrimination ban paves the way for expansion of life-saving DNA screening
A national legislative ban on life insurers discriminating against applicants based on genetic testing would…
S4 E4: The Oncology Journal Club Podcast ASCO 2026 Special – Part 1
From mouthwatering results in one of the most talked-about pancreatic cancer papers of the year, through to Bob Marley’s melanoma, this episode unpacks the latest oncology papers. With thanks to our Host Craig Underhill, joined by Dr Kate Clarke and Professor Christopher Jackson…
ASCO 2026: Selpercatinib shows decrease in risk of disease recurrence or death as adjuvant therapy for early-stage RET fusion-positive NSCLC
- AACR 2026: Investigational KRAS(ON) inhibitor zoldonrasib showed effective and durable responses in patients with advanced G12D-mutated lung cancer
- AACR 2026: Next-generation KRAS G12C inhibitor elisrasib elicited promising response rates in patients with advanced lung cancer
- Researchers explore potential link between COVID-19 and lung cancer risk
Culture, silence and safety: why oncology cannot afford to ignore its workforce
By Dr Dominique Lee Public trust in oncology relies on strong professional standards, transparent governance, and confidence that concerns will be…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.